Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Red Light Holland expands clinical shipments of psilocybin drug PEX010 to Canadian research centers.
TRIP
$14.61
+$0.61 +4.36%

Red Light Holland expands clinical shipments of psilocybin drug PEX010 to Canadian research centers.

Company Fundamentals
24 Apr 2026
Newsfile Corp
View Source
Bullish
pluang ai news

Red Light Holland Corp. has increased shipments of PEX010, a botanical psilocybin drug developed by Filament Health, to multiple Canadian universities for clinical trials. These shipments support studies on psilocybin-assisted therapy for alcohol use disorder, post-concussion symptoms, bipolar depression, and stress effects. The expansion highlights growing demand for pharmaceutical-grade natural psilocybin and advances Red Light's acquisition of Filament Health, which holds key patents and drug candidates. This progress positions Red Light to play a significant role in psychedelic medicine research and commercialization.

More News (TRIP)

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

Longleaf Small-Cap Fund Q2 sees gains from real estate and travel, Boston Beer drags performance.

In Q2 2026, Longleaf Small-Cap Fund saw positive contributions from New York real estate firms Alexander’s and Empire State Realty Trust, as well as travel company Tripadvisor. However, Boston Beer negatively impacted the quarter due to mixed short-t...

Market News
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App